Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:12:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page history shows a new revision entry v3.3.2 added and an older revision v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:10:17.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The government funding notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T03:27:32.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The new screenshot shows only cosmetic UI updates to the Record History page, with the version history and study status details remaining the same as in the old screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T18:32:56.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Significant update: added current operating status notice, current date, expanded study listing header with 2025-09-11 details, and revision v3.2.0; removed old date 2024-12-17 and revision v3.1.0.
    Difference
    14%
    Check dated 2025-10-06T04:24:55.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.2%
    Check dated 2025-09-28T23:46:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.